BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line ...
Frontiers

CNS demyelinating diseases: from biology to translational medicine

Demyelinating diseases of the central nervous system (CNS), including multiple sclerosis (MS) and related inflammatory and degenerative disorders, represent ...

ImmunityBio Announces ANKTIVA(R) Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership

ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer -- Commercial availability achieved within two months of announcing MENA ...
Prepared Foods

Botanicals Blur Line Between Immune Boosters, ‘Boasters’

Botanical ingredients like curcumin, ashwagandha and quercetin continue to gain traction in immune health, but questions ...
PharmiWeb

ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partners…

ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung ...
Frontiers

Real-world advances in inflammatory diseases: from population data to immunological mechanisms and clinical impact

Inflammatory diseases contain a broad spectrum of immune-mediated conditions, including autoimmune, autoinflammatory, allergic, dermatologic, ...